Prime Capital Investment Advisors, LLC Rani Therapeutics Holdings, Inc. Transaction History
Prime Capital Investment Advisors, LLC
- $6.63 Billion
- Q2 2024
A detailed history of Prime Capital Investment Advisors, LLC transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 13,882 shares of RANI stock, worth $29,291. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,882
Previous 13,882
-0.0%
Holding current value
$29,291
Previous $43,000
20.93%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RANI
# of Institutions
41Shares Held
2.96MCall Options Held
32.8KPut Options Held
4.2K-
Vanguard Group Inc Valley Forge, PA710KShares$1.5 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$1.04 Million2.18% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$946,3180.11% of portfolio
-
United Services Automobile Association San Antonio, TX312KShares$658,5200.03% of portfolio
-
Geode Capital Management, LLC Boston, MA151KShares$318,0480.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $51.7M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...